Home › NCT05968729
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
Who can join
Ages 18 to 30 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Able to read and speak English 2. Age 18 - 30 years old 3. Undergone ACLR surgery at the UConn Musculoskeletal Institute 4. Must not have any concomitant surgeries or injuries 5. Must be cleared to return-to-sport by a physician after they have completed rehabilitation 6. Must be within 1 month of having been cleared for return-to-sport 7. Must present with between-limb gait differences in load rate greater than 10% Exclusion Criteria: 1. Participants who have any recent inflammation, bleeding disorders, active bleeding, or infection within the lower limbs. 2. History of injuries to their patellar tendon 3. Cannot walk for extended periods of time 4. Cannot have had any back and/or lower extremity injury that affects their ability to move. 5. Cannot have difficulty or pain with walking, raising your arms, jogging, or jumping 6. Must not be allergic to tape.
About the study
The purpose of this work is to conduct a comparative research-focused study to evaluate the effectiveness of how purposefully induced asymmetric walking protocols restore healthy, symmetric limb loading in individuals following post-anterior cruciate ligament reconstruction (ACLR) surgery. Additionally, computational modeling and machine learning to model knee loading in the clinic to determine the optimal asymmetric walking protocol to restore healthy gait in post-ACLR individuals.
What is being tested
- Active Comparator: 0.25 m/s asymmetric session first (other)
- Active Comparator: 0.50 m/s asymmetric session first (other)
Sponsor: University of Connecticut · Participants: 40 · Started: Sep 1, 2022
Contact the study team
- Kristin Morgan, PhD · Phone: 860-486-8118
- Noah Davidson, BS · Phone: 860-486-8118
Official record on ClinicalTrials.gov — NCT05968729
Locations in the U.S.
| Connecticut | University of Connecticut, Storrs |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.